Ayahuasca: Pharmacology, neuroscience and therapeutic potential
Elisabet Domínguez‐clavé, Joaquim Soler, Matilde Elices, Juan Carlos Pascual, Enric Álvarez, Mario de la Fuente Revenga, Pablo Friedländer, Amanda Feilding, Jordi Riba
Brain Research Bulletin March 11, 2016 DOI: 10.1016/j.brainresbull.2016.03.002 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Anxiety Ayahuasca LSD Psilocybin |
| Keywords | Hallucinogen Pharmacology Psychotherapist |
| Citations | 220 |
| Key findings | Ayahuasca shows promise as a therapeutic tool by enhancing self-acceptance and allowing safe exposure to emotional events. |
Abstract
Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and used for ritual purposes by the indigenous populations of the Amazon. The use of a variation of the tea that combines B. caapi with the leaves of the shrub Psychotria viridis has experienced unprecedented expansion worldwide for its psychotropic properties. This preparation contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) from P. viridis, plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties from B. caapi. Acute administration induces a transient modified state of consciousness characterized by introspection, visions, enhanced emotions and recollection of personal memories. A growing body of evidence suggests that ayahuasca may be useful to treat substance use disorders, anxiety and depression. Here we review the pharmacology and neuroscience of ayahuasca, and the potential psychological mechanisms underlying its therapeutic potential. We discuss recent findings indicating that ayahuasca intake increases certain mindfulness facets related to acceptance and to the ability to take a detached view of one's own thoughts and emotions. Based on the available evidence, we conclude that ayahuasca shows promise as a therapeutic tool by enhancing self-acceptance and allowing safe exposure to emotional events. We postulate that ayahuasca could be of use in the treatment of impulse-related, personality and substance use disorders and also in the handling of trauma. More research is needed to assess the full potential of ayahuasca in the treatment of these disorders.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Argues that growing evidence suggests ayahuasca may be useful for anxiety and depression, with proposed mechanisms involving increased mindfulness, self-acceptance, and safe exposure to emotional events.
Synthesized
Comparable studies
Other narrative reviews on ayahuasca for anxiety, most cited first.
Citations in the library
Cited by 174
- Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics Frontiers in Psychiatry September 10, 2021
- Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT PLoS One April 23, 2019
- Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities The International Journal of Neuropsychopharmacology May 17, 2017
- Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking Psychopharmacology July 19, 2016
- Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness Current Neuropharmacology March 2, 2018
and 169 more in the library
Cites 62
- A default mode of brain function Proceedings of the National Academy of Sciences January 16, 2001
- Using Self-Report Assessment Methods to Explore Facets of Mindfulness Assessment January 27, 2006
- Mechanisms of mindfulness Journal of Clinical Psychology December 29, 2005
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Metacognitive awareness and prevention of relapse in depression: Empirical evidence. Journal of Consulting and Clinical Psychology 2002
and 57 more in the library